Clinical News and Research

RSS

Coffee Can Now Serve as a Biological Switch for Medicines

For many of us, a warm cup of coffee is how we start our day. For Texas A&M Health researchers, it may also offer a new way to control engineered cells in future medicines.

9 Jun 2026

Scientists Identify EHMT2 Enzyme as Main Cause of 5-FU Failure

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients.

9 Jun 2026

First Patient Enrolled in Oncopeptides’ Real-World Evidence Study Marina in Germany

Oncopeptides AB, a biotech company specializing in difficult-to-treat cancers, today announces that the first patient has been enrolled in the new real-world evidence study in Germany, named Marina.

9 Jun 2026

Scottish Biotech Bead Biopharma Emerges From Stealth Mode with Novel Cancer Drug Platform

Bead BioPharma, a Scottish life sciences company backed by Archangels, today announced its emergence from stealth mode following the submission of its first patent, a milestone that marks the company’s formal entry into one of the most commercially active sectors in global oncology.

9 Jun 2026

Creatine Linked to Cancer-Fighting Dendritic Cell Function

According to recent UCLA research, creatine, the organic acid that athletes and bodybuilders frequently use as a supplement, supercharges a crucial class of immune cells that activate and prime the body's primary cancer-fighting agents.

8 Jun 2026

Label-Free Raman Spectroscopy Accelerates Precision Phage Therapy

This study was led by Prof. Jian Xu (Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences) in collaboration with Prof. Hongzhou Lu (Shenzhen Third People's Hospital) and Prof. Jiadong Huang (University of Jinan).

8 Jun 2026

New Study Proves Research Models Accurately Replicate Cancer ecDNA Loops

Damage to DNA in cancer cells can lead to pieces breaking off chromosomes and floating away, like icebergs cracking off from a glacier. Just as icebergs are a threat to ships and their crew, these scattered bits of DNA loom large to physicians and cancer patients by having titanic effects on tumor progression and treatment resistance.

8 Jun 2026

Blood Signature Found to Predict Lung Cancer Risk Years Before Diagnosis

Researchers have identified a blood signature that can predict lung cancer risk years before diagnosis – significant findings that could enhance prevention strategies for Australia’s biggest cancer killer.

5 Jun 2026

New Antibiotic Compound Blocks Ribosome to Starve Dangerous Pathogens

Researchers at McMaster University have discovered a new antibiotic that kills some of the world's most dangerous and drug-resistant bacteria - and does so by targeting a previously unknown vulnerability, opening the door to an entirely new class of treatments.

5 Jun 2026

New Chromosome Packaging Discovery Explains Unlimited Growth in Cancer Cells

Published today in Nature, researchers at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center report a previously unrecognized change in how the cell's genetic material is packaged into structures called chromosomes.

4 Jun 2026

New Gene-Editing Strategy Ensures Quality Control in Stem Cell Therapies

A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a new strategy to significantly improve the precision and safety of CRISPR-Cas9 gene editing.

3 Jun 2026

Scientists Decode How T Cells Stop Deadly Viruses

T cells are among the immune system’s essential soldiers. They can inhibit tumor development and even combat serious infections.

3 Jun 2026

Bispecific Antibodies Target Tumors While Sparing Healthy Tissue

A new generation of bispecific antibodies effectively targets cancer cells, minimizing toxicity and enhancing treatment precision in preclinical studies.

3 Jun 2026

Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally

Evosep and Molecular You today announced a strategic collaboration to advance standardized, high-throughput multi-omic testing for personalized biomarker profiling.

From Evosep 3 Jun 2026

Introducing Evosep Proteomics to Standardize and Scale Proteomics for Research and Drug Development

Evosep announces the launch of Evosep Proteomics, an ecosystem designed to standardize and scale LC-MS-based proteomics for research and pharmaceutical drug development.

From Evosep 2 Jun 2026

NeuroSense Tracks Brain Fluid in Real Time to Prevent Deadly Infections

A research team led by the University of Waterloo has created a new monitoring system to save lives and significantly reduce health-care costs in brain-injury cases through the early detection of infections in intensive care units.

2 Jun 2026

Live-Imaging Techniques Reveal How Stem Cells Collectively Suppress Tumors

It all starts with a single cell.

2 Jun 2026

Redesigning Antibiotics to Overcome Bacterial Efflux Pump Resistance

A new way of designing antibiotics could support the discovery of new treatments for drug-resistant infections.

1 Jun 2026

Nanoparticles Boost Delivery of Lung Cancer Drugs 30-Fold

Lung cancer remains one of the world’s deadliest cancers, yet despite decades of effort to develop new drugs, many fail because they don’t stay in the body long enough to be effective or because they damage healthy organs.

1 Jun 2026

Heatwave: Extreme Heat and Air Pollution May Worsen Migraines, New Study Finds

Migraine is a moderate to severe headache disorder with unique characteristics that distinguish it from a regular headache. It is typically described as a throbbing pain, often on one side of the head.

30 May 2026